Plain-English translation of NCT07819435 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing PP405, a new topical gel applied directly to the scalp, to see if it can help regrow hair and slow hair loss in men with male pattern baldness. The study will follow participants for one year to evaluate how well the medication works and whether it is safe to use long-term. Researchers want to understand if this new treatment is better than a placebo (inactive gel) at helping men keep and regrow their hair.
Male pattern baldness affects millions of men and can significantly impact quality of life and self-esteem. Current treatment options are limited, so this trial exists to see if this new topical medication could offer men another effective choice for treating hair loss.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will apply either the study gel or a placebo gel to your scalp once daily for 24 weeks while researchers track your hair growth and any side effects. At the 24-week mark, participants will either continue with the same treatment or be switched to a different group, and you'll continue treatment for another 28 weeks. Throughout the year-long study, you'll have regular visits to have your scalp examined, photographed, and assessed for changes in hair growth.
AI-generated summary from trial data · Oct 3, 2026 · Not medical advice
United States